140 related articles for article (PubMed ID: 34979093)
1. Risk of Arterial Thromboembolism, Venous Thromboembolism, and Bleeding in Patients with Nephrotic Syndrome: A Population-Based Cohort Study.
Vestergaard SV; Birn H; Darvalics B; Nitsch D; Sørensen HT; Christiansen CF
Am J Med; 2022 May; 135(5):615-625.e9. PubMed ID: 34979093
[TBL] [Abstract][Full Text] [Related]
2. Kidney disease and risk of venous thromboembolism: a nationwide population-based case-control study.
Christiansen CF; Schmidt M; Lamberg AL; Horváth-Puhó E; Baron JA; Jespersen B; Sørensen HT
J Thromb Haemost; 2014 Sep; 12(9):1449-54. PubMed ID: 25040558
[TBL] [Abstract][Full Text] [Related]
3. Risk of thromboembolic and bleeding outcomes following hematological cancers: A Danish population-based cohort study.
Adelborg K; Corraini P; Darvalics B; Frederiksen H; Ording A; Horváth-Puhó E; Rørth M; Sørensen HT
J Thromb Haemost; 2019 Aug; 17(8):1305-1318. PubMed ID: 31054195
[TBL] [Abstract][Full Text] [Related]
4. Risk of bleeding and arterial cardiovascular events in patients with splanchnic vein thrombosis in Denmark: a population-based cohort study.
Søgaard KK; Adelborg K; Darvalics B; Horváth-Puhó E; Beyer-Westendorf J; Ageno W; Sørensen HT
Lancet Haematol; 2018 Oct; 5(10):e441-e449. PubMed ID: 30201587
[TBL] [Abstract][Full Text] [Related]
5. High absolute risks and predictors of venous and arterial thromboembolic events in patients with nephrotic syndrome: results from a large retrospective cohort study.
Mahmoodi BK; ten Kate MK; Waanders F; Veeger NJ; Brouwer JL; Vogt L; Navis G; van der Meer J
Circulation; 2008 Jan; 117(2):224-30. PubMed ID: 18158362
[TBL] [Abstract][Full Text] [Related]
6. Preadmission use of glucocorticoids and risk of cardiovascular events in patients with ischemic stroke.
Sundbøll J; Darvalics B; Horváth-Puhó E; Adelborg K; Laugesen K; Schmidt M; Henderson VW; Sørensen HT
J Thromb Haemost; 2018 Nov; 16(11):2175-2183. PubMed ID: 30179297
[TBL] [Abstract][Full Text] [Related]
7. Adults with first-time nephrotic syndrome had increased risk for thromboembolic events, higher near time of diagnosis.
Mithoowani S; Lim W
Ann Intern Med; 2022 Jun; 175(6):JC70. PubMed ID: 35667069
[TBL] [Abstract][Full Text] [Related]
8. Risk of arterial and venous thromboembolism in patients with atrial fibrillation or flutter: A nationwide population-based cohort study.
Sundbøll J; Hováth-Puhó E; Adelborg K; Ording A; Schmidt M; Bøtker HE; Sørensen HT
Int J Cardiol; 2017 Aug; 241():182-187. PubMed ID: 28473169
[TBL] [Abstract][Full Text] [Related]
9. Migraine and risk of cardiovascular diseases: Danish population based matched cohort study.
Adelborg K; Szépligeti SK; Holland-Bill L; Ehrenstein V; Horváth-Puhó E; Henderson VW; Sørensen HT
BMJ; 2018 Jan; 360():k96. PubMed ID: 29386181
[TBL] [Abstract][Full Text] [Related]
10. Venous thromboembolism in patients hospitalized with nephrotic syndrome.
Kayali F; Najjar R; Aswad F; Matta F; Stein PD
Am J Med; 2008 Mar; 121(3):226-30. PubMed ID: 18328307
[TBL] [Abstract][Full Text] [Related]
11. Initiation of statins and risk of venous thromboembolism: Population-based matched cohort study.
Skajaa N; Szépligeti SK; Horváth-Puhó E; Ghanima W; Hansen JB; Sørensen HT
Thromb Res; 2019 Dec; 184():99-104. PubMed ID: 31715545
[TBL] [Abstract][Full Text] [Related]
12. Risk factors of venous thromboembolism in focal segmental glomerulosclerosis with nephrotic syndrome.
Li SJ; Tu YM; Zhou CS; Zhang LH; Liu ZH
Clin Exp Nephrol; 2016 Apr; 20(2):212-7. PubMed ID: 26220221
[TBL] [Abstract][Full Text] [Related]
13. Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort study.
Pottegård A; Lund LC; Karlstad Ø; Dahl J; Andersen M; Hallas J; Lidegaard Ø; Tapia G; Gulseth HL; Ruiz PL; Watle SV; Mikkelsen AP; Pedersen L; Sørensen HT; Thomsen RW; Hviid A
BMJ; 2021 May; 373():n1114. PubMed ID: 33952445
[TBL] [Abstract][Full Text] [Related]
14. Incidence of bleeding and thromboembolism and impact on overall survival in adult patients with hemophagocytic lymphohistiocytosis: A 20-year provincial retrospective cohort study.
Croden J; Bilston L; Taparia M; Grossman J; Sun HL
J Thromb Haemost; 2022 Mar; 20(3):671-683. PubMed ID: 34856055
[TBL] [Abstract][Full Text] [Related]
15. Primary Nephrotic Syndrome and Risks of ESKD, Cardiovascular Events, and Death: The Kaiser Permanente Nephrotic Syndrome Study.
Go AS; Tan TC; Chertow GM; Ordonez JD; Fan D; Law D; Yankulin L; Wojcicki JM; Zheng S; Chen KK; Khoshniat-Rad F; Yang J; Parikh RV
J Am Soc Nephrol; 2021 Sep; 32(9):2303-2314. PubMed ID: 34362836
[TBL] [Abstract][Full Text] [Related]
16. Comparative risk of major bleeding with rivaroxaban and warfarin: Population-based cohort study of unprovoked venous thromboembolism.
Kohn CG; Bunz TJ; Beyer-Westendorf J; Coleman CI
Eur J Haematol; 2019 Feb; 102(2):143-149. PubMed ID: 30328143
[TBL] [Abstract][Full Text] [Related]
17. Venous thromboembolism and subsequent hospitalisation due to acute arterial cardiovascular events: a 20-year cohort study.
Sørensen HT; Horvath-Puho E; Pedersen L; Baron JA; Prandoni P
Lancet; 2007 Nov; 370(9601):1773-9. PubMed ID: 18037081
[TBL] [Abstract][Full Text] [Related]
18. Twenty-four-Year Trends in Incidence and Mortality of Nephrotic Syndrome: A Population-Based Cohort Study.
Vestergaard SV; Birn H; Jensen SK; Sørensen HT; Nitsch D; Christiansen CF
Epidemiology; 2023 May; 34(3):411-420. PubMed ID: 36730008
[TBL] [Abstract][Full Text] [Related]
19. Prophylactic anticoagulants to prevent venous thromboembolism in patients with nephrotic syndrome-A retrospective observational study.
Welander F; Holmberg H; Dimény E; Jansson U; Själander A
PLoS One; 2021; 16(7):e0255009. PubMed ID: 34319998
[TBL] [Abstract][Full Text] [Related]
20. Venous thrombosis and risk of cancer in patients with arterial cardiovascular disease.
Schmidt SA; Farkas DK; Pedersen L; Prandoni P; Sørensen HT
Thromb Res; 2015 Jan; 135(1):96-101. PubMed ID: 25467083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
